Novus Therapeutics Announces $10.7 Million Registered Direct Offering Priced At-the-Market - Yahoo Finance

Novus Therapeutics Announces $10.7 Million Registered Direct Offering Priced At-the-Market  Yahoo Finance

Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat ...



Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment

BTS Clinical Statement on air travel for passengers with respiratory disease - Thorax (BMJ)